Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 626019, 9 pages
http://dx.doi.org/10.1155/2015/626019
Research Article

Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy

1Department of Radiology, Affiliated Hospital of BeiHua University, JiLin 132011, China
2College of Basic Medical Sciences, Changchun University of Chinese Medicine, Changchun, Jilin 130117, China

Received 29 June 2014; Accepted 9 September 2014

Academic Editor: Ilias Migdalis

Copyright © 2015 Duo Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Baldassarre, F. A. Giannone, L. Napoli et al., “The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives,” Liver International, vol. 33, no. 9, pp. 1298–1308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-W. Chen, V. Boyartchuk, and B. C. Lewis, “Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells,” Neoplasia, vol. 11, no. 9, pp. 835–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. Q. L. Cui and G. Almazan, “IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases,” Journal of Neurochemistry, vol. 100, no. 6, pp. 1480–1493, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Daulatzai, “Early stages of pathogenesis in memory impairment during normal senescence and alzheimer's disease,” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. 355–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. De Paula, Q.-L. Cui, S. Hossain, J. Antel, and G. Almazan, “The PTEN inhibitor bisperoxovanadium enhances myelination by amplifying IGF-1 signaling in rat and human oligodendrocyte progenitors,” GLIA, vol. 62, no. 1, pp. 64–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Etgen, O. González-Flores, and B. J. Todd, “The role of insulin-like growth factor-I and growth factor-associated signal transduction pathways in estradiol and progesterone facilitation of female reproductive behaviors,” Frontiers in Neuroendocrinology, vol. 27, no. 4, pp. 363–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. F. Zhi, J. B. Prins, and T. H. Marwick, “Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications,” Endocrine Reviews, vol. 25, no. 4, pp. 543–567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Fernandez, A. M. Fernandez, C. Lopez-Lopez, and I. Torres-Aleman, “Emerging roles of insulin-like growth factor-I in the adult brain,” Growth Hormone & IGF Research, vol. 17, no. 2, pp. 89–95, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gozzi, V. Crestan, G. Turrini, M. Clemens, and A. Bifone, “Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit,” Psychopharmacology, vol. 209, no. 1, pp. 37–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. B. H. Harvey, “Is major depressive disorder a metabolic encephalopathy?” Human Psychopharmacology: Clinical and Experimental, vol. 23, no. 5, pp. 371–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. P. Head, J. N. Peart, M. Panneerselvam et al., “Loss of caveolin-1 accelerates neurodegeneration and aging,” PLoS ONE, vol. 5, no. 12, Article ID e15697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Hematulin, D. Sagan, F. Eckardt-Schupp, and S. Moertl, “NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade,” Cellular Signalling, vol. 20, no. 12, pp. 2276–2285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. E. Hills, N. J. Brunskill, and P. E. Squires, “C-peptide as a therapeutic tool in diabetic nephropathy,” American Journal of Nephrology, vol. 31, no. 5, pp. 389–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Lim, J. Hong, C.-T. Liu et al., “Common variants in and near IRS1 and subclinical cardiovascular disease in the Framingham Heart Study,” Atherosclerosis, vol. 229, no. 1, pp. 149–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Meng, D. Zhang, and H. Yang, “Effects of amyloid precursor protein 17 peptide on the protection of diabetic encephalopathy and improvement of glycol metabolism in the diabetic rat,” Journal of Diabetes Research, vol. 2013, Article ID 689841, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Rogawski, “What is the rationale for new treatment strategies in Alzheimer's disease?” CNS Spectrums, vol. 9, no. 7, supplement 5, pp. 6–31, 2004. View at Google Scholar · View at Scopus
  17. A. P. Ross, E. C. Bruggeman, A. W. Kasumu, J. G. Mielke, and M. B. Parent, “Non-alcoholic fatty liver disease impairs hippocampal-dependent memory in male rats,” Physiology and Behavior, vol. 106, no. 2, pp. 133–141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. A. Stoica, V. A. Movsesyan, P. M. Lea IV, and A. I. Faden, “Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3β, and induction of the mitochondrial-dependent intrinsic caspase pathway,” Molecular and Cellular Neuroscience, vol. 22, no. 3, pp. 365–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Strong, “The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis,” Amyotrophic Lateral Sclerosis, vol. 9, no. 6, pp. 323–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H.-S. Suh, M.-L. Zhao, L. Derico, N. Choi, and S. C. Lee, “Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: Differential regulation by inflammatory mediators,” Journal of Neuroinflammation, vol. 10, article 37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Thind and M. N. Sabbagh, “Pathological correlates of cognitive decline in Alzheimer's disease,” Panminerva Medica, vol. 49, no. 4, pp. 191–195, 2007. View at Google Scholar · View at Scopus
  22. J. Trojan, J.-F. Cloix, M.-Y. Ardourel, M. Chatel, and D. D. Anthony, “Insulin-like growth factor type I biology and targeting in malignant gliomas,” Neuroscience, vol. 145, no. 3, pp. 795–811, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. R. L. Tuttle, N. S. Gill, W. Pugh et al., “Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα,” Nature Medicine, vol. 7, no. 10, pp. 1133–1137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. H. U. Ung, A. R. Moehlig, R. A. Kudla et al., “Proton-bound dimers of 1-methylcytosine and its derivatives: vibrational and NMR spectroscopy,” Physical Chemistry Chemical Physics, vol. 15, no. 43, pp. 19001–19012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Vafopoulou and C. G. H. Steel, “Insulin-like and testis ecdysiotropin neuropeptides are regulated by the circadian timing system in the brain during larval-adult development in the insect Rhodnius prolixus (Hemiptera),” General and Comparative Endocrinology, vol. 179, no. 2, pp. 277–288, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. I. Vinik, T. Erbas, K. S. Stansberry, and G. L. Pittenger, “Small fiber neuropathy and neurovascular disturbances in diabetes mellitus,” Experimental and Clinical Endocrinology and Diabetes, vol. 109, no. 2, pp. S451–S473, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Von Gunten, K. Ebbing, A. Imhof, P. Giannakopoulos, and E. Kövari, “Brain aging in the oldest-old,” Current Gerontology and Geriatrics Research, vol. 2010, Article ID 358531, 10 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. X. K. Wang, M. L. Michaelis, and E. K. Michaelis, “Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability,” Current Genomics, vol. 11, no. 8, pp. 618–633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. B. K. Wicker, H. P. Hutchens, Q. Wu, A. T. Yeh, and J. D. Humphrey, “Normal basilar artery structure and biaxial mechanical behaviour,” Computer Methods in Biomechanics and Biomedical Engineering, vol. 11, no. 5, pp. 539–551, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Epaud, F. Aubey, J. Xu et al., “Knockout of insulin-like growth factor-1 receptor impairs distal lung morphogenesis,” PLoS ONE, vol. 7, no. 11, Article ID e48071, 2012. View at Google Scholar · View at Scopus
  31. S. Jiang, P. Du, L. An, G. Yuan, and Z. Sun, “Anti-diabetic effect of Coptis Chinensis polysaccharide in high-fat diet with STZ-induced diabetic mice,” International Journal of Biological Macromolecules, vol. 55, pp. 118–122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. A. F. Sima, W. Zhang, C. W. Kreipke, J. A. Rafols, and W. H. Hoffman, “Inflammation in diabetic encephalopathy is prevented by C-peptide,” Review of Diabetic Studies, vol. 6, no. 1, pp. 37–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. M. de la Monte, “Insulin resistance and Alzheimer's disease,” BMB Reports, vol. 42, no. 8, pp. 475–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Havrankova, J. Roth, and M. Brownstein, “Insulin receptors are widely distributed in the central nervous system of the rat,” Nature, vol. 272, no. 5656, pp. 827–829, 1978. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Plum, M. Schubert, and J. C. Brüning, “The role of insulin receptor signaling in the brain,” Trends in Endocrinology and Metabolism, vol. 16, no. 2, pp. 59–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Gasparini and H. Xu, “Potential roles of insulin and IGF-1 in Alzheimer's disease,” Trends in Neurosciences, vol. 26, no. 8, pp. 404–406, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Wada, H. Yokoo, T. Yanagita, and H. Kobayashi, “New twist on neuronal insulin receptor signaling in health, disease, and therapeutics,” Journal of Pharmacological Sciences, vol. 99, no. 2, pp. 128–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. C. C. Huang, C. C. Lee, and K. S. Hsu, “The role of insulin receptor signaling in synaptic plasticity and cognitive function,” Chang Gung Medical Journal, vol. 33, no. 2, pp. 115–125, 2010. View at Google Scholar · View at Scopus
  39. A. Gallardo, E. Lerma, D. Escuin et al., “Increased signalling of EGFR and IGF-1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas,” British Journal of Cancer, vol. 106, no. 8, pp. 1367–1373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. T. R. Kim, E. W. Cho, S. G. Paik, and I. G. Kim, “Hypoxia-induced SM22α in A549 cells activates the IGF-1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy,” FEBS Letters, vol. 586, no. 4, pp. 303–309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Goto, A. Iwase, T. Harata et al., “IGF1-induced AKT phosphorylation and cell proliferation are suppressed with the increase in PTEN during luteinization inhuman granulosa cells,” Reproduction, vol. 137, no. 5, pp. 835–842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. de Butte-Smith, R. S. Zukin, and A. M. Etgen, “Effects of global ischemia and estradiol pretreatment on phosphorylation of Akt, CREB and STAT3 in hippocampal CA1 of young and middle-aged female rats,” Brain Research, vol. 1471, pp. 118–128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Racaniello, A. Cardinale, C. Mollinari et al., “Phosphorylation changes of CaMKII, ERK1/2, PKB/ Akt kinases and CREB activation during early long-term potentiation at Schaffer collateral-CA1 mouse hippocampal synapses,” Neurochemical Research, vol. 35, no. 2, pp. 239–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. T. C. Jackson, A. Rani, A. Kumar, and T. C. Foster, “Regional hippocampal differences in AKT survival signaling across the lifespan: implications for CA1 vulnerability with aging,” Cell Death and Differentiation, vol. 16, no. 3, pp. 439–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. V. Znamensky, K. T. Akama, B. S. McEwen, and T. A. Milner, “Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites,” The Journal of Neuroscience, vol. 23, no. 6, pp. 2340–2347, 2003. View at Google Scholar · View at Scopus